High-Risk Breast Cancer


  • Joseph Ragaz
  • Irving M. Ariel

Table of contents

  1. Front Matter
    Pages I-XIII
  2. Introduction

  3. General

    1. Front Matter
      Pages 25-25
    2. J. E. Price, I. J. Fidler
      Pages 27-46
  4. Surgery

    1. Front Matter
      Pages 85-85
    2. P. I. Pressman
      Pages 108-120
    3. I. A. Olivotto, V. E. Basco, S. M. Jackson
      Pages 121-138
  5. Radiotherapy

    1. Front Matter
      Pages 139-139
    2. J. M. Robertson, D. H. Clarke, A. Martinez
      Pages 141-159
  6. Hormonal Therapy

    1. Front Matter
      Pages 161-161
    2. S. R. Ebbs, D. Riley, M. Baum
      Pages 184-196
  7. Chemotherapy—General

  8. Therapy — Adjuvant

    1. Front Matter
      Pages 235-235
    2. A. Goldhirsch, R. D. Gelber
      Pages 237-249
    3. P. Valagussa, R. Silvestrini, G. Bonadonna
      Pages 250-259
  9. Chemotherapy — Metastatic

    1. Front Matter
      Pages 283-283
  10. Inflammatory Breast Cancer

    1. Front Matter
      Pages 317-317
    2. S. Waldman, L. M. Toonkel, E. Davila
      Pages 319-333
    3. J. P. Ferriere, A. Janin, F. Kwiatkowski, M. Legros, Y. J. Bignon, P. Chollet et al.
      Pages 334-344
    4. A. Janin, R. Plagne, J. P. Ferriere, Y. Fonck, M. De Latour, M. Bourges
      Pages 345-353
  11. Stage III Breast Cancer

    1. Front Matter
      Pages 355-355
    2. E. Davila, L. M. Toonkel
      Pages 357-381
  12. Autologous Bone Marrow Transplantation

  13. Therapeutic Aspects of Tumor Biology Research

    1. Front Matter
      Pages 471-471
  14. Summary

    1. Front Matter
      Pages 491-491
  15. Back Matter
    Pages 511-517

About this book


The many advances in breast cancer research, as well as the large quantity of published material, make it very difficult to gain insight into the global aspects of cancer management. To follow and understand all the new developments is becoming a major challenge. For this reason, the editors decided to bring together a group of top researchers in breast cancer to provide a comprehensive, yet readable conceptual review of the state of the art of breast cancer diagnosis and therapy. The proposal to focus the review on the quantitative assessment of the risk at diagnosis, the determination of which may permit selective therapies for individual patients, was met with enthusiastic approval, resulting in the present volume with contributions by the leading investigators in the field. While the volume relating to diagnosis, published re­ cently, focused on efforts leading to refinement at diagnosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid­ ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua­ tion of the first book. A refined risk assessment at diagnosis and the application of the most suitable treatments to well­ selected individuals are the most important steps towards avoiding the present worrisome reality of overtreating the low risk and undertreating the high-risk patients. The first few chapters of the present volume offer an insight into the general management of early breast cancer.


Breast Cancer Brustkrebs Krebstherapie Tumor biopsy carcinoma diagnosis surgery

Editors and affiliations

  • Joseph Ragaz
    • 1
  • Irving M. Ariel
    • 2
  1. 1.Medical OncologyBritish Columbia Cancer AgencyVancouverCanada
  2. 2.Foundation for Clinical Research Inc.New YorkUSA

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1991
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-74730-4
  • Online ISBN 978-3-642-74728-1
  • Buy this book on publisher's site